Evidence map›Paper›PMID 34099689›Full record

ArticleNature communications2021

High throughput screening identifies SOX2 as a super pioneer factor that inhibits DNA methylation maintenance at its binding sites.

Ludovica Vanzan, Hadrien Soldati, Victor Ythier, Santosh Anand, Simon M G Braun, Nicole Francis, Rabih Murr

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Cell reprogramming: methods, mechanisms and applications.Cell regeneration (London, England) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Ludovica VanzanDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.ORCID 0000-0003-2182-3607
Hadrien SoldatiDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
Victor YthierDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
Santosh AnandDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.ORCID 0000-0003-2287-0229
Simon M G BraunDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.ORCID 0000-0003-2622-9914
Nicole FrancisInstitut de Recherches Cliniques de Montréal (IRCM) and Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Canada.ORCID 0000-0002-1810-2959
Rabih MurrDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland. rabih.murr@unige.ch.ORCID 0000-0002-3346-6590
University of Geneva · CHMontreal Clinical Research Institute · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Binding of mammalian transcription factors (TFs) to regulatory regions is hindered by chromatin compaction and DNA methylation of their binding sites. Nevertheless, pioneer transcription factors (PFs), a distinct class of TFs, have the ability to access nucleosomal DNA, leading to nucleosome remodelling and enhanced chromatin accessibility. Whether PFs can bind to methylated sites and induce DNA demethylation is largely unknown. Using a highly parallelized approach to investigate PF ability to bind methylated DNA and induce DNA demethylation, we show that the interdependence between DNA methylation and TF binding is more complex than previously thought, even within a select group of TFs displaying pioneering activity; while some PFs do not affect the methylation status of their binding sites, we identified PFs that can protect DNA from methylation and others that can induce DNA demethylation at methylated binding sites. We call the latter super pioneer transcription factors (SPFs), as they are seemingly able to overcome several types of repressive epigenetic marks. Finally, while most SPFs induce TET-dependent active DNA demethylation, SOX2 binding leads to passive demethylation, an activity enhanced by the co-binding of OCT4. This finding suggests that SPFs could interfere with epigenetic memory during DNA replication.

Indexed as

Binding SitesDNA MethylationHigh-Throughput Screening AssaysAnimalsChromatinDNADNA DemethylationDNA ReplicationEpigenomicsGene ExpressionMiceNucleosomesOctamer Transcription Factor-3Protein BindingRNA, Small InterferingSf9 CellsChromatinDNANucleosomesOctamer Transcription Factor-3POU5F1 protein, humanRNA, Small InterferingSOX2 protein, humanSOXB1 Transcription FactorsTranscription Factors

Identifiers

PMID34099689
PMCPMC8184831
OpenAlexW3166148623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.